ID: ALA3349162

Max Phase: Preclinical

Molecular Formula: C27H44N2O2

Molecular Weight: 428.66

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C

Standard InChI:  InChI=1S/C27H44N2O2/c1-24(2,3)16-25(4,5)29-23(31)20-10-9-18-17-8-11-21-27(7,15-13-22(30)28-21)19(17)12-14-26(18,20)6/h13,15,17-21H,8-12,14,16H2,1-7H3,(H,28,30)(H,29,31)/t17-,18-,19-,20+,21?,26-,27+/m0/s1

Standard InChI Key:  DFOUYXDPGWIRCV-KBFNAUCFSA-N

Associated Targets(Human)

Steroid 5-alpha-reductase 2 937 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Androgen Receptor 5522 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 428.66Molecular Weight (Monoisotopic): 428.3403AlogP: 5.23#Rotatable Bonds: 3
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 0.50CX LogP: 4.63CX LogD: 4.63
Aromatic Rings: 0Heavy Atoms: 31QED Weighted: 0.65Np Likeness Score: 1.34

References

1. Rasmusson GH, Reynolds GF, Steinberg NG, Walton E, Patel GF, Liang T, Cascieri MA, Cheung AH, Brooks JR, Berman C..  (1986)  Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.,  29  (11): [PMID:3783591] [10.1021/jm00161a028]

Source